BG
OXFD

BlackRock Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

BlackRock Group’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,643
Closed -$26K – 3060
2016
Q1 		$26K Buy
+2,643
New +$27.1K ﹤0.01% 3010
2014
Q3 		– Sell
-77,902
Closed -$1.31M – 2898
2014
Q2 		$1.31M Sell
77,902
-96,154
-55% -$1.73M ﹤0.01% 1676
2014
Q1 		$3.49M Buy
174,056
+33,656
+24% +$728K ﹤0.01% 1262
2013
Q4 		$2.72M Buy
+140,400
New +$2.48M ﹤0.01% 1339

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock Group's OXFD Position: Q2 2016 in Review

BlackRock Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2016, closing a stake of 2,643 shares — an estimated $26K sold.

BlackRock Group first reported a position in OXFD in Q4 2013 and held it in 4 quarters. The position peaked at $3.49M in Q1 2014. 56 funds tracked by Wall St. Rank hold OXFD as of Q2 2016.

  • BlackRock Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • BlackRock Group sold 2,643 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2016, an estimated $26K.
  • BlackRock Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 4 quarters.
  • BlackRock Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $3.49M in Q1 2014.
  • 56 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2016.

Based on BlackRock Group's 13F filing for Q2 2016, filed 10 Aug 2016.